Why did net profit fall even as revenue grew?

TTK Healthcare's net profit shrank 19% to ₹6,568 lakhs because of exceptional items. These one-off charges reduced the bottom line despite a 7% topline increase.

What is the dividend payout?

The board recommended a dividend of ₹10 per share for FY26. It is an unchanged, routine annual declaration.

What does the executive chairman's reappointment signal?

It is a standard governance action for a company with stable leadership. The filing does not indicate any impending strategic or operational shift.

Earnings · Pharmaceuticals · Small cap

TTK Healthcare profit falls 19% on exceptional charges

Revenue grew 7%, but the bottom line shrank. The filing is routine.

TTKHLTCARE By Tipsheet Editorial 30 May 2026 · 1:53 PM IST Verify on BSE · NSE

Mkt cap₹1,304 cr

P/E19.85×

ROE7.67%

Debt / eq.0.02

Div yld1.09%

₹6,568 lakhs FY26 net profit, down 19% year-on-year.

What's new

Revenue rose 7% to ₹85,728 lakhs in FY26.
Net profit dropped 19% to ₹6,568 lakhs due to exceptional items.
Board recommended a ₹10 per share dividend and reappointed the executive chairman.

Why this matters

This is a routine filing for a stable, low-volatility micro-cap. The results were anticipated, and the governance moves are procedural. The filing adds no new information for investors to act on.

What we're watching

The specific nature of the exceptional items weighing on profit.
Any commentary on underlying volume or margin trends.
Management's outlook for the next fiscal year.

The full read

TTK Healthcare's FY26 results are stable. Revenue climbed 7% to ₹85,728 lakhs. Net profit fell 19% to ₹6,568 lakhs, dragged by exceptional items. The board maintained the ₹10 per share dividend and reappointed the executive chairman. Both are procedural. No new strategy. No catalyst for a re-rating. The numbers match expectations. For a micro-cap with a steady, low-volatility business, that's the story.

Questions answered

Why did net profit fall even as revenue grew?: TTK Healthcare's net profit shrank 19% to ₹6,568 lakhs because of exceptional items. These one-off charges reduced the bottom line despite a 7% topline increase.
What is the dividend payout?: The board recommended a dividend of ₹10 per share for FY26. It is an unchanged, routine annual declaration.
What does the executive chairman's reappointment signal?: It is a standard governance action for a company with stable leadership. The filing does not indicate any impending strategic or operational shift.

Mentioned: ₹10 dividend · ₹85,728 lakhs revenue · ₹6,568 lakhs net profit

Primary source BSE · NSE · Tijori

An independent reading of the company's own disclosure — the primary filing above is the final word.

Company snapshot

TTK Healthcare Ltd.

Pharmaceuticals

₹1,287 cr

P/E 19.60×

Latest quarter · Mar 2026

Sales₹218 cr

Net profit₹22 cr

Op. margin+5.1%

EPS₹15.40

Strength & growth

Debt / equity0.02×

Current ratio5.91×

Sales CAGR+5.2%

EPS CAGR+4.6%